Table 4.

Risk of mortality at 3 months according to treatment by time-updated Cox regression analysis

Treatment	Unadjusted HR (95% CI)	Adjusted HRa (95% CI)
SXT (reference group)	1	1
Pentamidine	3.5 (2.4–4.9)	3.3 (2.2–5.0)
Clindamycin/primaquine	1.2 (0.8–2.0)	1.6 (0.9–2.8)
Other drugs	0.7 (0.3–1.5)	1.4 (0.6–3.6)

SXT, trimethoprim/sulfamethoxazole.

Analysis of last episode of PCP.

Goodness of fit: log likelihood = –932.8, χ² = 133.3, P < 0.00001.

^aAdjusted for PaO₂ at admission, age, CD4 cell count, year of diagnosis, bacterial co-infection, previous PCP prophylaxis and country.